Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Download App
简
繁
简
繁
EN
Home
Latest
Finance
IPO
ETF
Tech
Overseas
Video
Research
Latest
19:11
[ Z.AI(02513.HK) closed 16.55% lower, the Hang Seng Software & Services Sector saw divergent trends ] By the close of trading on Jul 30, 2026, Z.AI(02513.HK) saw a loss of 16.55% in its share price, closing at HKD 862. During the session, it reached an intraday high of HKD 1048 and touched an intraday low of HKD 840.
Tag:
Z.AI
02513.HK
19:11
[ FOREST CABIN(02657.HK) will spend HKD 15.24 million to repurchase 284.2 thousand shares on Jul 30, 2026 ] FOREST CABIN(02657.HK) will spend HKD 15.24 million to repurchase 284.2 thousand shares on Jul 30, 2026 .
Tag:
FOREST CABIN
02657.HK
19:11
[ PLOVER BAY TECH(01523.HK): 2026 Interim Report - Profit Attributable to Shareholders stood at USD 27.72 million, YoY increase of 27.94% ] July 30, 2026, PLOVER BAY TECH(01523.HK) released its Interim Report for the period ended December 31, 2026, Total Revenue stood at USD 74.6 million, increased by 18.51% YoY
Tag:
PLOVER BAY TECH
01523.HK
18:03
[ Sirnaomics-B (02257.HK): First Patient Dosed in Phase 2 Clinical Trial of STP705 for Medical Aesthetics ] NewTimeSpace News: Sirnaomics Ltd. (02257.HK) announced that the first patient has been successfully dosed in a Phase 2 multicenter clinical trial evaluating STP705 for medical aesthetics. The trial aims to systematically assess the clinical efficacy of STP705 in achieving targeted subcutaneous fat reduction through local administration, leveraging the Group's proprietary PNP oligonucleotide delivery platform, which enables site-specific gene regulation to drive controlled adipocyte clearance.
Tag:
SIRNAOMICS-B
02257.HK
Medical Aesthetics
Clinical Trial
17:59
[ CANbridge-B (01228.HK): GORYNIN® (Velaglucerase Beta) Initiates Registration and Commercialization Preparations in North Africa, Advancing Global Gaucher Disease Market Strategy ] NewTimeSpace News: CANbridge Pharmaceuticals Inc. (01228.HK) announced on July 30 that GORYNIN®, a treatment for Gaucher disease, has commenced registration and commercialization preparations in the North African market. GORYNIN® is the Company's first self-developed enzyme replacement therapy, approved in China in May 2025. The Company stated it will pursue a global market strategy, though it has yet to generate any sales revenue from North Africa, where the registration process remains subject to regulatory approval.
Tag:
CANBRIDGE-B
01228.HK
Commercialization
17:54
[ Henlius (02696.HK): First Patient Dosed in Phase 1 Trial of Trispecific Antibody HLX3902 Targeting STEAP1×CD3×CD28 ] NewTimeSpace News: Shanghai Henlius Biotech, Inc. (02696.HK) announced that the first patient has been dosed in a Phase 1 clinical study in China for its self-developed HLX3902 Injection, a STEAP1×CD3×CD28 trispecific antibody, for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and other advanced solid tumors. To date, no trispecific antibody of the same target class has been approved for marketing globally.
Tag:
HENLIUS
02696.HK
Clinical Trial
17:49
[ MGM China (02282.HK): Executive Director Ms. Liu Zhenni Appointed as Chief Financial Officer ] NewTimeSpace News: MGM China Holdings Limited (02282.HK) announced that Executive Director Ms. Liu Zhenni will be appointed as Chief Financial Officer with effect from August 1, 2026.
Tag:
MGM CHINA
02282.HK
Appointment
CFO
17:41
[ SSY Group (02005.HK): Cimetidine Injection and Acetylcysteine Solution for Inhalation Obtain Manufacturing Registration Approvals ] NewTimeSpace News: SSY Group Limited (02005.HK) announced that the Group has obtained a drug manufacturing registration approval from the NMPA for Cimetidine Injection (2ml:0.2g), classified as a Category 3 chemical drug and deemed to have passed the consistency evaluation. The product is primarily indicated for the treatment of gastrointestinal ulcers. In addition, the Group has obtained a registration approval for Acetylcysteine Solution for Inhalation (3ml:0.3g), classified as a Category 4 chemical drug and deemed to have passed the consistency evaluation. The product is indicated for the treatment of respiratory diseases accompanied by excessive thick mucus secretions.
Tag:
SSY Group
02005.HK
manufacturing registration approval certificate
17:34
[ TRULY INT'L(00732.HK): Executive Director Mr. Zhang Rongxiang Resigns ] NewTimeSpace News: Truly International Holdings Limited (00732.HK) announced that Mr. Zhang Rongxiang has resigned as Executive Director with effect from July 31, 2026, due to his decision to devote more time to other personal commitments. Mr. Zhang has confirmed that he has no disagreement with the Board.
Tag:
TRULY INT
00732.HK
resignation
17:24
[ SKB BIO (06990.HK): NMPA Accepts sNDA for Core Product Sac-TMT in First-Line TNBC Treatment ] NewTimeSpace News: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (06990.HK) announced that the NMPA has accepted a supplemental New Drug Application (sNDA) for its core product, the TROP2-targeted ADC sacituzumab tirumotecan (sac-TMT, JIATAILEI®), for a new indication: the first-line treatment of recurrent or metastatic triple-negative breast cancer (TNBC) in patients with PD-L1 CPS < 10 or those who have previously received PD-1/PD-L1 inhibitors at an early stage. The application has been included in the priority review and approval procedure, marking the sixth accepted indication application for sac-TMT.
Tag:
SKB BIO
06990.HK
Priority Review
17:08
[ ROKAE (SHANDONG) ROBOTICS (03752.HK): Interim Revenue Expected to Surge by Over 127%, Turnaround in Adjusted Net Profit ] NewTimeSpace News: ROKAE (SHANDONG) ROBOTICS announced on 30 July that the Group expects its revenue for the first half of 2026 to be no less than RMB 400 million, representing a year-on-year growth of at least 127.4%; net loss will not exceed RMB 86 million, narrowing by no less than 4.8% year-on-year; the Group will swing to profit in terms of adjusted net profit.
Tag:
ROKAE (SHANDONG) ROBOTICS
03752.HK
17:03
[ Ling Yue Services Group (02165.HK): Appointment of Zhang Guanghu as Independent Non-executive Director and Chairman of Audit Committee ] NewTimeSpace News: Ling Yue Services Group announced on 30 July that Mr. Zhang Guanghu has been appointed as the Company’s Independent Non-executive Director and Chairman of the Audit Committee, with effect from 29 July 2026.
Tag:
Ling Yue Services Group
02165.HK
16:57
[ Pacific Online Limited (00543.HK): Profit Warning, Interim Loss Widens to Approximately RMB 32 Million to RMB 42 Million ] NewTimeSpace News: Pacific Online Limited announced on 30 July that based on information currently available to the Board, the Group expects to record a net loss attributable to owners of the Company of approximately RMB 32 million to RMB 42 million for the first half of 2026.
Tag:
Pacific Online Limited
00543.HK
16:30
[ SUNWODA HKEX Listing Application Lapses; 5 Consecutive Years as Global No.1 with 34.3% Market Share in Mobile Phone Batteries ] NewTimeSpace News: The listing application submitted by Sunwoda Electronic Co., Ltd. to HKEX on 30 January 2026 has lapsed upon the expiry of the six-month period. According to China Insights Consultancy, measured by shipment volume in 2024, the Company is the world’s largest lithium-ion battery manufacturer. It holds a 34.3% market share in the global mobile phone battery segment, ranking first worldwide for five consecutive years, and secures the second position in the global laptop and tablet battery market with a 21.6% market share. Having nearly 30 years of experience in the lithium battery sector, the Group’s product portfolio covers consumer batteries, power batteries and energy storage systems.
Tag:
SUNWODA
IPO
IPO application lapsed
16:18
[ ZHONGXIN HOME HKEX Listing Application Lapses; Ranks First Among Chinese PVC Flooring Export Manufacturers ] NewTimeSpace News: The listing application submitted by Jiangsu Zhongxin Pridon New Material Co., Ltd. to HKEX on 30 January 2026 has lapsed upon the expiry of the six-month period. According to Frost & Sullivan, measured by global sales area of SPC flooring in 2024, the Company ranks first among Chinese PVC flooring export manufacturers with a market share of 1.02%; and ranks eighth globally by sales area of PVC flooring worldwide in 2024, with a market share of 0.61%. Its products are sold widely overseas. Overseas revenue accounts for 99.4% of total revenue, of which the US market contributes 81.2%.
Tag:
ZHONGXIN HOME
IPO
IPO application lapsed
16:15
[ Anhui Haimacloud Technology Co., Ltd. HKEX Listing Application Lapses; Leading Provider of Real-Time Cloud Rendering Services for Cloud Gaming in China ] NewTimeSpace News: The listing application submitted by Anhui Haimacloud Technology Co., Ltd. to HKEX on 30 January 2026 has lapsed upon the expiry of the six-month period. According to China Insights Consultancy, measured by revenue in 2024, the Company ranks first among suppliers of real-time cloud rendering services for cloud gaming scenarios in China with a market share of 17.9%, making it China’s largest GPUaaS provider for real-time cloud rendering in cloud gaming.
Tag:
Haimacloud
IPO
IPO application lapsed
16:14
[ ASCOTT: Secures 9 Projects in Vietnam in H1 2026, Adding Over 3,200 Units ] NewTimeSpace News: ASCOTT announced on 30 July that it had signed nine management agreements in Vietnam during the first half of 2026, adding a total of more than 3,200 units. The newly inked projects expand its portfolio of operational and pipeline properties in Vietnam by over 30%.
Tag:
ASCOTT
Business Development
16:08
[ EAGLERISE ELECTRIC HKEX Listing Application Lapses; Second Among Chinese Suppliers of Global Medium-Voltage Transformer Equipment ] NewTimeSpace News: The listing application submitted by Eaglerise Electric & Electronic (CHINA) Co., Ltd. to HKEX on 30 January 2026 has lapsed upon the expiry of the six-month period. Measured by revenue in 2024, the Company ranks second among Chinese suppliers in the global medium-voltage transformer equipment sector, second among Chinese suppliers for new energy transformer equipment, third among Chinese suppliers of data centre transformer equipment, and fifth worldwide in the lighting power supply sector.
Tag:
EAGLERISE ELECTRIC
IPO
IPO application lapsed
16:03
[ CIMIC Group: UGL Secures Stage 2 Contract for Neoen’s Goyder Battery Energy Storage Project in South Australia ] NewTimeSpace News: CIMIC Group announced on 30 July that its subsidiary UGL has been selected by Neoen and Tesla to deliver Stage 2 of the Goyder Battery Energy Storage Project in South Australia.
Tag:
CIMIC Group
Battery Energy Storage Project
16:02
[ TAILG TECHNOLOGY HKEX Listing Application Lapses; Ranks 3rd in Global Light Electric Vehicle Market ] NewTimeSpace News: The listing application submitted by TAILG Technology Co., Ltd. to HKEX on 30 January 2026 has lapsed upon the expiry of the six-month period. According to Frost & Sullivan, measured by revenue in 2024, the Group ranks third in the global light electric vehicle market with a market share of 5.2%, and third in China’s electric two-wheeler market with a market share of 12.7%. The Company is the pioneer that defined "long-range electric two-wheelers" in Chinese Mainland.
Tag:
TAILG Technology
IPO
招股书失效
Previous
1..
229
230
231
232
233
..577
Next
577
pages total
Latest
More
10-19 21:25 |
LYGEND RESOURCE (02245.HK): Guarantee for Wholly-Owned Subsidiary's RMB500m Credit Facility
10-19 20:00 |
GCL TECH (03800.HK): Proposes RMB 2.5bn Acquisition of 81.91% of Sichuan GCL Lithium; Connected Transaction
10-19 19:49 |
LEADS BIOLABS-B (09887.HK): Six Abstracts on Weilixin and LBL-034 Published at ESMO 2026; Three Chosen for Oral Presentations
10-19 19:31 |
ZIJIN GOLD INTL (02259.HK): 9M Gold Output ~41 Tonnes, Up 28%; Attributable Profit US$2.01bn, Up 123%
10-19 19:14 |
RIBOLIFE-B (06938.HK): Issues 14,087,085 Consideration Shares to Buy Remaining 49.71% of Ribocure
10-19 19:07 |
SF HOLDING (06936.HK): September Express Revenue RMB 20.835bn, Down 0.09%; Supply Chain and International Up 28.13%
10-19 19:00 |
ZHAOJIN MINING (01818.HK): Wang Ligang Resigns as ED and Board Secretary; Yang Tiejiang Appointed ED
10-19 18:55 |
SHENZHEN INVEST (00604.HK): Q3 Contracted Sales RMB 1.814bn; Holiday Subscriptions RMB 886mn
10-19 18:50 |
MABWELL-B (02493.HK): Phase II Data for 9MW2821 in TNBC to Be Presented at ESMO 2026; ORR 30.0%
10-19 18:40 |
METIS TECHBIO-P (07666.HK): Strategic LNP Delivery Collaboration with Eli Lilly; Up to ~US$1.1bn Milestones
Top Stories
Weekly Hong Kong ETF AUM Changes (Second Week of October 2026)
HK Stock Connect Insight | YUNFENG FIN (00376.HK) proposes sale of Yunfeng Financial Markets to streamline the licensing structure; southbound holding ratio falls to 0.91%
HK Stock Connect Weekly: HSI Slips 0.10% for the Week as the Semiconductor Chain Rebounds on Friday-20261016
Offshore Trust Insight | GREEN TEA GROUP (06831.HK): 1H Revenue Up 16.8% YoY, Controlling Shareholders' Approximately 54.29% Stake Expected to Be Unlocked Next Month
HK Newly Listed Stocks Weekly Tracker: CHINA SANDI Gains 84.62%, Z.AI Tops with Average Daily Turnover of HK$2.147 Billion-20261016
Scan QR Code
Download App
×
Share to WeChat
Open WeChat, use "Scan," and share to my Moments